Assetmark Inc. Has $3.59 Million Stock Holdings in STERIS plc (NYSE:STE)

Assetmark Inc. raised its stake in shares of STERIS plc (NYSE:STE) by 30.3% during the 4th quarter, HoldingsChannel reports. The firm owned 17,470 shares of the medical equipment provider’s stock after purchasing an additional 4,060 shares during the quarter. Assetmark Inc.’s holdings in STERIS were worth $3,591,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Ashton Thomas Securities LLC acquired a new stake in shares of STERIS in the third quarter worth $25,000. Human Investing LLC acquired a new stake in shares of STERIS in the fourth quarter worth $31,000. Anfield Capital Management LLC grew its stake in shares of STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares during the last quarter. Central Pacific Bank Trust Division grew its stake in shares of STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC grew its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 137 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Up 0.3 %

Shares of NYSE:STE opened at $233.02 on Monday. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The company’s fifty day moving average is $216.96 and its 200-day moving average is $222.70. The company has a market capitalization of $22.89 billion, a PE ratio of 49.47 and a beta of 0.92.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be paid a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 0.98%. STERIS’s dividend payout ratio is presently 48.41%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. JMP Securities restated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Finally, Stephens reiterated an “overweight” rating and set a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.